Market Access Advancements and Challenges in “Drug-Companion Diagnostic Test” Co-Development in Europe

The pharma ecosphere is witnessing a measured transformation from the one-size-fits-all or blockbuster model of drugs to more informed and tailored personalized treatments that facilitate higher safety and efficacy for a relevant sub-population. However, with several breakthroughs still in a nascent...

Descripción completa

Detalles Bibliográficos
Autores principales: Akhmetov, Ildar, Ramaswamy, Rakshambikai, Akhmetov, Illias, Thimmaraju, Phani Kishore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493497/
https://www.ncbi.nlm.nih.gov/pubmed/26075972
http://dx.doi.org/10.3390/jpm5020213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493497/
https://www.ncbi.nlm.nih.gov/pubmed/26075972
http://dx.doi.org/10.3390/jpm5020213

Ejemplares similares